tiprankstipranks
Trending News
More News >
GeneTether Therapeutics, Inc. (TSE:RIZE)
:RIZE
Canadian Market

GeneTether Therapeutics, Inc. (RIZE) Financial Statements

Compare
3 Followers

GeneTether Therapeutics, Inc. Financial Overview

GeneTether Therapeutics, Inc.'s market cap is currently $2.27M. The company's EPS TTM is $-0.02; its P/E ratio is ―; GeneTether Therapeutics, Inc. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -747.28K$ -1.72M$ -1.64M$ -71.96K$ -86.23K
EBITDA$ 0.00$ -1.71M$ -1.64M$ -71.96K$ -509.00
Net Income$ -688.36K$ -1.71M$ -1.64M$ -73.97K$ -86.74K
Balance Sheet
Cash & Short-Term Investments$ 1.36M$ 1.80M$ 179.83K$ 45.39K$ 10.11K
Total Assets$ 1.41M$ 1.94M$ 370.45K$ 45.39K$ 13.12K
Total Debt$ 0.00$ 0.00$ 0.00$ 122.13K$ 20.28K
Net Debt$ -1.36M$ -1.80M$ -179.83K$ 76.75K$ 10.16K
Total Liabilities$ 38.59K$ 87.42K$ 213.22K$ 123.16K$ 21.39K
Stockholders' Equity$ 1.37M$ 1.86M$ 157.22K$ -77.78K$ -8.27K
Cash Flow
Free Cash Flow$ -464.86K$ -1.18M$ -740.26K$ -69.06K$ -95.46K
Operating Cash Flow$ -464.86K$ -1.18M$ -740.26K$ -69.06K$ -95.46K
Investing Cash Flow$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Financing Cash Flow$ 0.00$ 3.00M$ 874.71K$ 104.33K$ 80.00K
Currency in USD

GeneTether Therapeutics, Inc. Earnings and Revenue History

GeneTether Therapeutics, Inc. Debt to Assets

GeneTether Therapeutics, Inc. Cash Flow

GeneTether Therapeutics, Inc. Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis